Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods

被引:257
作者
Klepser, ME
Ernst, EJ
Lewis, RE
Ernst, ME
Pfaller, MA
机构
[1] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[2] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA
关键词
D O I
10.1128/AAC.42.5.1207
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study was designed to examine the effects of antifungal carryover, agitation, and starting inoculum on the results of time-kill tests conducted with various Candida species, Two isolates each of Candida albicans, Candida tropicalis, and Candida glabrata were utilized. Test antifungal agents included fluconazole, amphotericin B, and LY303366. Time-kill tests were conducted in RPMI 1640 medium buffered with morpholinepropanesulfonic acid (MOPS) to a pH of 7.0 and incubated at 35 degrees C. Prior to testing, the existence of antifungal carryover was evaluated at antifungal concentrations ranging from Ix to 16x MIC by four plating methods: direct plating of 10, 30, and 100 mu l of test suspension and filtration of 30 mu l of test suspension through a 0.45-mu m-pore-size filter. Time-kill curves were performed with each isolate at drug concentrations equal to 2x MIG, using a starting inoculum of approximately 10(5) CFU/ml, nd incubated with or without agitation, Last, inoculum experiments were conducted over three ranges of starting inocula: 5 x 10(2) to 1 x 10(4), > 1 x 10(4) to 1 x 10(6), and >1 x 10(6) to 1 x 10(8) CFU/ml, Significant antifungal carryover (>25% reduction in CFU/milliliter from the control value) was observed with amphotericin B and fluconazole; however, carryover was eliminated with filtration. Agitation did not appreciably affect results, The starting inoculum did not significantly affect the activity of fluconazole or amphotericin B; however, the activity of LY303366 may be influenced by the starting inoculum, Before antifungal time-kill curve methods are routinely employed by investigators, methodology should be scrutinized and standardized procedures should be developed.
引用
收藏
页码:1207 / 1212
页数:6
相关论文
共 18 条
  • [1] ERNST EJ, 1997, 37 INT C ANT AG CHEM, P127
  • [2] ERNST EJ, 1997, 37 INT C ANT AG CHEM, P159
  • [3] Ernst Erika J., 1997, Pharmacotherapy, V17, P1093
  • [4] Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp.
    Ernst, ME
    Klepser, ME
    Wolfe, EJ
    Pfaller, MA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 26 (3-4) : 125 - 131
  • [5] Growth medium effect on the antifungal activity of LY 303366
    Klepser, ME
    Ernst, EJ
    Ernst, ME
    Pfaller, MA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (04) : 227 - 231
  • [6] Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans
    Klepser, ME
    Wolfe, EJ
    Jones, RN
    Nightingale, CH
    Pfaller, MA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1392 - 1395
  • [7] KLEPSER ME, 1997, 37 INT C ANT AG CHEM, P109
  • [8] KLEPSER ME, IN PRESS J ANTIMICRO
  • [9] KLEPSER ME, 1997, 37 INT C ANT AG CHEM, P158
  • [10] Lund Brian C., 1997, Pharmacotherapy, V17, P1094